Nuveen Asset Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-166,656
| Closed | -$207K | – | 3330 |
|
|
2024
Q1 | $207K | Sell |
166,656
-273,245
| -62% | -$339K | ﹤0.01% | 3177 |
|
|
2023
Q4 | $462K | Sell |
439,901
-20,412
| -4% | -$21.4K | ﹤0.01% | 3032 |
|
|
2023
Q3 | $3.15M | Buy |
460,313
+258,896
| +129% | +$1.77M | ﹤0.01% | 2099 |
|
|
2023
Q2 | $2.09M | Buy |
201,417
+12,156
| +6% | +$126K | ﹤0.01% | 2318 |
|
|
2023
Q1 | $1.53M | Sell |
189,261
-12,336
| -6% | -$99.8K | ﹤0.01% | 2442 |
|
|
2022
Q4 | $3.18M | Sell |
201,597
-19,827
| -9% | -$312K | ﹤0.01% | 2167 |
|
|
2022
Q3 | $3.49M | Sell |
221,424
-29,290
| -12% | -$461K | ﹤0.01% | 2106 |
|
|
2022
Q2 | $3.5M | Sell |
250,714
-66,826
| -21% | -$933K | ﹤0.01% | 2158 |
|
|
2022
Q1 | $5.12M | Buy |
317,540
+15,384
| +5% | +$248K | ﹤0.01% | 2048 |
|
|
2021
Q4 | $4.39M | Buy |
302,156
+30,066
| +11% | +$437K | ﹤0.01% | 2194 |
|
|
2021
Q3 | $4.94M | Buy |
272,090
+88,303
| +48% | +$1.6M | ﹤0.01% | 2215 |
|
|
2021
Q2 | $3.23M | Buy |
+183,787
| New | +$3.23M | ﹤0.01% | 2477 |
|
|
2020
Q2 | – | Sell |
-110,000
| Closed | -$115K | – | 3203 |
|
|
2020
Q1 | $115K | Buy |
110,000
+8,849
| +9% | +$9.25K | ﹤0.01% | 3047 |
|
|
2019
Q4 | $191K | Sell |
101,151
-14,287
| -12% | -$27K | ﹤0.01% | 3081 |
|
|
2019
Q3 | $125K | Sell |
115,438
-12,522
| -10% | -$13.6K | ﹤0.01% | 3153 |
|
|
2019
Q2 | $280K | Buy |
+127,960
| New | +$280K | ﹤0.01% | 3110 |
|